TY - JOUR
T1 - Anti-Angiogenic Activity of Mouse N-/C-terminal deleted Endostatin
AU - Cho, Heeyeong
AU - Kim, Woo Jean
AU - Lee, Sae Woo
AU - Kim, Young Mi
AU - Choi, Eu Yul
AU - Park, Yong Suk
AU - Kwon, Young Guen
AU - Kim, Kyu Won
N1 - Copyright:
Copyright 2004 Elsevier Science B.V., Amsterdam. All rights reserved.
PY - 2001/5/31
Y1 - 2001/5/31
N2 - Endostatin, a proteolytic fragment of collagen XVIII, is a potent inhibitor of angiogenesis and the growth of several primary tumors. However, the opinions on the activity of endostatin derivatives deleted N- or C- terminal are still controversial. In this regard, we produced mouse endostatin and its derivatives in the prokaryotic system, and studied their anti-tumor activity. The [3H]-thymidine incorporation assay demonstrated that N-terminal deleted mouse endostatin, and a C- and N-terminal deleted mutant, effectively inhibited the proliferation of human umbilical vein endothelial cells (HUVECs). The biological activity of endostatin was also shown by its in vivo anti-angiogenic ability on the chorioallantoic membrane (CAM) of a chick embryo. Treatment of 200 ng of mouse endostatin, or N-terminal deleted mouse endostatin, inhibited capillary formation of CAM 45 to 71%, which is comparative to a 80% effect of positive control, 1 μg of retinoic acid. An in vivo mouse tumor growth assay showed that N-terminal deleted mouse endostatin, and the N-/C-terminal deleted mutant, significantly repressed the growth of B16F10 melanoma cells in mice as did the full-length mouse endostatin. According to these results, N- and N-/C-terminal deleted mouse endostatins are the potent inhibitors of tumor growth and angiogenesis.
AB - Endostatin, a proteolytic fragment of collagen XVIII, is a potent inhibitor of angiogenesis and the growth of several primary tumors. However, the opinions on the activity of endostatin derivatives deleted N- or C- terminal are still controversial. In this regard, we produced mouse endostatin and its derivatives in the prokaryotic system, and studied their anti-tumor activity. The [3H]-thymidine incorporation assay demonstrated that N-terminal deleted mouse endostatin, and a C- and N-terminal deleted mutant, effectively inhibited the proliferation of human umbilical vein endothelial cells (HUVECs). The biological activity of endostatin was also shown by its in vivo anti-angiogenic ability on the chorioallantoic membrane (CAM) of a chick embryo. Treatment of 200 ng of mouse endostatin, or N-terminal deleted mouse endostatin, inhibited capillary formation of CAM 45 to 71%, which is comparative to a 80% effect of positive control, 1 μg of retinoic acid. An in vivo mouse tumor growth assay showed that N-terminal deleted mouse endostatin, and the N-/C-terminal deleted mutant, significantly repressed the growth of B16F10 melanoma cells in mice as did the full-length mouse endostatin. According to these results, N- and N-/C-terminal deleted mouse endostatins are the potent inhibitors of tumor growth and angiogenesis.
UR - http://www.scopus.com/inward/record.url?scp=0035592827&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035592827&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0035592827
VL - 34
SP - 206
EP - 211
JO - BMB Reports
JF - BMB Reports
SN - 1976-6696
IS - 3
ER -